Table 1 Frequency of anti-Sm, anti-U1snRNP, anti-Ro/SS-A, anti-La/SS-B, anti-Jo-1(histRNA-Synthetase) and anti-Scl-70(Topoisomerase I) autoantibodies in patient sera
anti-U1snRNP | anti-Sm | anti-Ro/SS-A | anti-La/SS-B | anti-Jo-1 | anti-Scl-70 | Other anti-rRNP | |
|---|---|---|---|---|---|---|---|
SLE (n = 42) | 19 | 6 | 30 | 13 | 0 | 0 | 7 |
SLE + SS (n = 11) | 1 | 1 | 11 | 7 | 0 | 0 | 0 |
SLE + RD (n = 5) | 4 | 0 | 1 | 1 | 0 | 0 | 0 |
SLE + NS (n = 8) | 9 | 1 | 2 | 1 | 0 | 0 | 6 |
SLE + APS (n = 3) | 2 | 0 | 0 | 0 | 0 | 0 | 2 (NS) |
SS (n = 24) | 1 | 0 | 24 | 11 | 0 | 0 | 0 |
SS + RA (n = 3) | 0 | 0 | 3 | 2 | 0 | 0 | 0 |
SS + APS (n = 2) | 0 | 0 | 2 | 0 | 0 | 0 | 0 |
SS + PBC (n = 3) | 0 | 0 | 3 | 0 | 0 | 0 | 0 |
PM (n = 4) | 0 | 0 | 3 | 0 | 4 | 0 | 0 |
PM + SS (n = 1) | 0 | 0 | 1 | 0 | 1 | 0 | 0 |
ASS (n = 1) | 0 | 0 | 1 | 0 | 1 | 0 | 0 |
SSc (n = 11) | 4 | 0 | 0 | 0 | 0 | 10 | 0 |
MCTD (n = 3) | 3 | 0 | 0 | 0 | 0 | 0 | 0 |
Other (n = 13) | 6 | 0 | 7 | 0 | 0 | 0 | 0 |
NHS (n = 16) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Prevalence | 27.8 % | 6.7 % | 56.7 % | 23 % | 4.8 % | 9.6 % |